These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 487688)

  • 1. Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy.
    van Rooijen GJ; Boer P; Dorhout Mees EJ; Geyskes GG
    Clin Pharmacol Ther; 1979 Oct; 26(4):420-7. PubMed ID: 487688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension.
    Teeuw AH; Leenen FH; Geyskes GG; Boer P
    Clin Pharmacol Ther; 1979 Mar; 25(3):294-302. PubMed ID: 367678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
    Ishizaki T; Oyama Y; Suganuma T; Sasaki T; Nakaya H; Shibuya T; Sato T
    Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol.
    Hansson L; Westerlund A; Aberg H; Karlberg BE
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):361-5. PubMed ID: 786662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension.
    Epstein SE; LUbbe WF
    S Afr Med J; 1977 Nov; 52(22):875-9. PubMed ID: 343273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians.
    Salako LA; Falase AO; Aderounmu AF; Walker O
    Afr J Med Med Sci; 1990 Mar; 19(1):57-61. PubMed ID: 2109522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
    McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
    Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of propranolol and atenolol on plasma renin activity and systolic time intervals in borderline hypertension.
    González-Gómez A; García-Barreto D; Gamio Capestany F; Hernández-Cañero A; Fong Chi S
    Cor Vasa; 1982; 24(6):422-8. PubMed ID: 6764167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atenolol and chlorthalidone in combination for hypertension.
    Bateman DN; Dean CR; Mucklow JC; Bulpitt CJ; Dollery CT
    Br J Clin Pharmacol; 1979 Apr; 7(4):357-63. PubMed ID: 375958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison.
    Curry RC; Schwartz KM; Urban PL
    South Med J; 1988 Nov; 81(11):1401-6, 1411. PubMed ID: 3055324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.
    Velasco M; Guevara J; Morillo J; Ramírez A; Urbina-Quintana A; Hernández-Pieretti O
    Br J Clin Pharmacol; 1980 May; 9(5):499-504. PubMed ID: 6994790
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension.
    Wilkinson R; Stevens IM; Pickering M; Robson V; Hawkins T; Kerr DN; Harry JD
    Br J Clin Pharmacol; 1980 Jul; 10(1):51-9. PubMed ID: 6994760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol.
    England JD
    Aust N Z J Med; 1981 Feb; 11(1):35-40. PubMed ID: 7018482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG; Shanks RG
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with tibalosine in essential hypertension.
    Staessen J; Fagard R; Fiocchi R; Lijnen P; M'Buyamba-Kabangu JR; Amery A
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):162-76. PubMed ID: 3516092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.
    Geyskes GG; Boer P; Vos J; Leenen FH; Mees EJ
    Circ Res; 1975 Jun; 36(6 Suppl 1):248-56. PubMed ID: 1093756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioselectivity of atenolol in asthmatic patients.
    Ellis ME; Sahay JN; Chatterjee SS; Cruickshank JM; Ellis SH
    Eur J Clin Pharmacol; 1981; 21(3):173-6. PubMed ID: 7032947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One and three doses of propranolol a day in hypertension.
    van den Brink G; Boer P; van Asten P; Dorhout Mees EJ; Geyskes GG
    Clin Pharmacol Ther; 1980 Jan; 27(1):9-15. PubMed ID: 7351121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.
    De Plaen JF; Amery A; Reybrouck T
    Eur J Clin Pharmacol; 1976 Sep; 10(5):297-303. PubMed ID: 789082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.